Boston Scientific Corporation has been the subject of 272 FDA enforcement/approval records tracked by Argus HQ, compared to 2 for GlaxoSmithKline LLC.
Boston Scientific Corporation: 0 warning letters, 272 recalls, 0 approval records, 0 Form 483s.
GlaxoSmithKline LLC: 0 warning letters, 2 recalls, 0 approval records, 0 Form 483s.
Side by side
Boston Scientific Corporation — Warning letters0
GlaxoSmithKline LLC — Warning letters0
Boston Scientific Corporation — Recalls272
GlaxoSmithKline LLC — Recalls2
Boston Scientific Corporation — Approval records0
GlaxoSmithKline LLC — Approval records0
Boston Scientific Corporation — Form 483s0
GlaxoSmithKline LLC — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Boston Scientific Corporation vs GlaxoSmithKline LLC: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/boston-scientific-corporation-vs-glaxosmithkline-llc
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗